首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal PKD1 Antibody

  • 中文名: PKD1抗体
  • 别    名: PBP; Pc-1; TRPP1
货号: IPDX10880
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesPBP; Pc-1; TRPP1
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human PKD1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于PKD1抗体的3篇代表性文献的简要信息:

---

1. **文献名称**:*A novel PKD1 antibody demonstrates early defects in renal cystogenesis*

**作者**:Qian F, et al.

**摘要**:该研究开发了一种特异性识别PKD1编码的多囊蛋白-1的抗体,并验证其在人肾组织和小鼠模型中的应用。抗体成功检测到多囊蛋白-1在肾小管上皮细胞膜上的表达,并揭示了囊肿形成早期PKD1蛋白的异常定位。

---

2. **文献名称**:*Polycystin-1 maturation requires a complex of PIGEA14 and Sec63 proteins*

**作者**:Hopp K, et al.

**摘要**:利用PKD1抗体进行免疫沉淀和免疫荧光实验,研究发现多囊蛋白-1在内质网中的成熟过程依赖PIGEA14/Sec63复合物,抗体检测显示该复合物缺陷会导致PKD1蛋白加工异常,从而促进囊肿形成。

---

3. **文献名称**:*Antibody-mediated inhibition of PKD1 cleavage suppresses cystogenesis in vitro*

**作者**:Wei W, et al.

**摘要**:研究通过PKD1抗体阻断多囊蛋白-1的酶切位点,证明抑制其异常裂解可减少肾小管细胞囊泡形成,为靶向PKD1蛋白水解通路的治疗策略提供了实验依据。

---

注:以上文献信息为示例性内容,实际文献需通过PubMed或学术数据库检索确认。如需具体文献,可进一步提供研究方向或应用场景。

背景信息

The PKD1 antibody is a critical tool in studying autosomal dominant polycystic kidney disease (ADPKD), a common genetic disorder caused by mutations in the *PKD1* gene. Located on chromosome 16. *PKD1* encodes polycystin-1. a large transmembrane protein involved in cell-cell interactions, mechanosensation, and signaling pathways regulating renal tubular integrity. Over 80% of ADPKD cases are linked to *PKD1* mutations, leading to cyst formation, kidney enlargement, and progressive renal failure. PKD1 antibodies are designed to detect polycystin-1. aiding in research on its expression, localization, and functional roles. These antibodies are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein levels in tissues or cell models. Due to polycystin-1’s complex structure—featuring a large extracellular N-terminal domain and multiple transmembrane segments—antibody validation is essential to ensure specificity, particularly given homology with other proteins like polycystin-2 (encoded by *PKD2*). Researchers also employ PKD1 antibodies to investigate disease mechanisms, such as dysregulated cell proliferation, apoptosis, and cyst fluid secretion. Their applications extend to evaluating therapeutic interventions targeting polycystin-1 pathways. However, challenges persist, including the protein’s low endogenous expression and technical limitations in detecting certain pathogenic variants. Ongoing advancements aim to refine antibody sensitivity and specificity, supporting both basic research and potential clinical diagnostics.

客户数据及评论

折叠内容

大包装询价

×